---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-103843"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2022-04-13T23:59:59+00:00"
generated_at: "2026-06-26T07:40:59.363353+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Minerva Neurosciences hosts roluperidone update webcast; no specific details in 8-K

## Summary
- Company held an investor webcast on April 13, 2022, to discuss updates on roluperidone.
- The 8-K filing includes only a cover page and dial-in information for the webcast.
- No clinical data, regulatory milestones, or financial guidance were disclosed in the filing.
- Investors must access the webcast replay or presentation to learn the actual update content.

## SEC filing metadata
- accession: 0001193125-22-103843
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2022-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312522103843/0001193125-22-103843-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312522103843/d333769d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-103843
- JSON: https://secwatch.observer/filing/0001193125-22-103843.json
- Plain text: https://secwatch.observer/filing/0001193125-22-103843.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.